Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP402118.RAv11Yu376C2uJY3aT1tcrkwughBXLeJzmiugGkupHD18130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP402118.RAv11Yu376C2uJY3aT1tcrkwughBXLeJzmiugGkupHD18130_assertion type Assertion NP402118.RAv11Yu376C2uJY3aT1tcrkwughBXLeJzmiugGkupHD18130_head.
- NP402118.RAv11Yu376C2uJY3aT1tcrkwughBXLeJzmiugGkupHD18130_assertion wasGeneratedBy ECO_0000203 NP402118.RAv11Yu376C2uJY3aT1tcrkwughBXLeJzmiugGkupHD18130_provenance.
- NP402118.RAv11Yu376C2uJY3aT1tcrkwughBXLeJzmiugGkupHD18130_assertion wasDerivedFrom befree-20150227 NP402118.RAv11Yu376C2uJY3aT1tcrkwughBXLeJzmiugGkupHD18130_provenance.
- NP402118.RAv11Yu376C2uJY3aT1tcrkwughBXLeJzmiugGkupHD18130_assertion SIO_000772 24124571 NP402118.RAv11Yu376C2uJY3aT1tcrkwughBXLeJzmiugGkupHD18130_provenance.
- NP402118.RAv11Yu376C2uJY3aT1tcrkwughBXLeJzmiugGkupHD18130_assertion evidence source_evidence_literature NP402118.RAv11Yu376C2uJY3aT1tcrkwughBXLeJzmiugGkupHD18130_provenance.
- NP402118.RAv11Yu376C2uJY3aT1tcrkwughBXLeJzmiugGkupHD18130_assertion description "[Targeting wild-type and mutationally activated FGFR4 in rhabdomyosarcoma with the inhibitor ponatinib (AP24534).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP402118.RAv11Yu376C2uJY3aT1tcrkwughBXLeJzmiugGkupHD18130_provenance.